Testosterone Treatment and Prostate Cancer Risk

Testosterone Treatment and Prostate Cancer Risk

The goal of this program is to improve the management of testosterone deficiency (TD) in men using testosterone therapy (TT) without the risk for prostate cancer (PC). After hearing and assimilating this program, the clinician will be better able to:Recognize the absence of risk for aggressive PC with TT.

  • Provider:Lippincott Continuing Medical Education Institute, Inc.
  • Activity Link: https://www.audio-digest.org/Specialties/Urology
  • Start Date: 2024-11-15 06:00:00
  • End Date: 2024-11-15 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.